Showing results (591-600 of 634) with videos related to

Sort By:
Pageof 64
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 2, 2019
How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare CancersJi Hyun Park, Ji Sung Lee, HaYeong Koo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2019
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164Dung T Le, Tae Won Kim, Eric Van Cutsem, et al.
The Lancet. Oncology|December 17, 2021
Sotorasib for previously treated colorectal cancers with KRAS<sup>G12C</sup> mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trialMarwan G Fakih, Scott Kopetz, Yasutoshi Kuboki, et al.
The New England Journal of Medicine|December 2, 2020
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal CancerThierry André, Kai-Keen Shiu, Tae Won Kim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 24, 2015
SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherinSeong Joon Park, Seung-Mi Kim, Jai-Hee Moon, et al.
Chinese Journal of Cancer|December 24, 2016
Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumabMasahito Kotaka, Ruihua Xu, Kei Muro, et al.
International Journal of Biological Sciences|January 29, 2026
TM4SF5-mediated KEAP1 Regulation in Hepatocytes Irrelevant to NRF2 Expression and Activity Promotes Oxidative Stress and Inflammation to Develop Metabolic Dysfunction-Associated Steatotic Liver DiseaseEun-Ae Shin, Haesong Lee, Kyung-Hee Pyo, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2019
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarkerHeejung Chae, Deokhoon Kim, Changhoon Yoo, et al.
Investigational New Drugs|November 1, 2013
NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutantsJae-Sik Shin, Seung-Woo Hong, Jai-Hee Moon, et al.
Nucleic Acid Therapeutics|May 30, 2025
Developmental and Reproductive Toxicity Testing Strategies for Oligonucleotides: A Workshop ProceedingsBethany R Hannas, Sara M Bender, Eileen Blasi, et al.
Pageof 64